ATRA-IV references

Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999;51:691–743.

Muindi JR, Frankel SR, Huselton C et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 1992;52:2138–2142.

Muindi J, Frankel SR, Miller WH Jr. et al. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid “resistance” in patients with acute promyelocytic leukemia. Blood 1992;79:299–303.

Williams A, Schary W, Lopez-Berestein G, Smith WB, Smitherman M. Pharmacokinetics of intravenous liposomal all-trans-retinoic acid (ATRA) compared to oral ATRA in healthy subjects. Blood 2000;96:185b.